Brief: Hemcheck Sweden Q3 Loss After Items Narrows To SEK 3.4 Mln

Bio Vitos Pharma AB

16/11/2023 07:43

Nov 16 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q3 REVENUE SEK 103,082 VERSUS SEK 286,258 YEAR AGO
    * Q3 LOSS AFTER ITEMS SEK 3.4 MILLION VERSUS LOSS SEK 3.9
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr3mC0R 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))